Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Calidi Biotherapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Calidi Biotherapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Peoples George | Director | – | Aug 19, 2026 | 1 |
| Leftwich Scott | Director | 130,650 | Aug 19, 2026 | 1 |
| Stewart Alan R. | Director | 28,976 | Aug 19, 2026 | 1 |
| Jackson Andrew C. | Chief Financial Officer | 2,500 | Aug 19, 2026 | 1 |
| Schoeneck James A | Director | 76,134 | Aug 19, 2026 | 1 |
| Poma Eric E | Chief Executive Officer | 25,000 | Aug 19, 2026 | 1 |
| Fernandez Santidrian Antonio | Chief Scientific Officer | – | Aug 19, 2026 | 1 |
| Sanders Corazon (Corsee) D. | Director | – | Aug 19, 2026 | 1 |
| Camaisa Allan | Director | 76,952Indirect | Dec 16, 2025 | 1 |
| Minev Boris Radoslavov | Interim Chief Medical Officer | – | Jun 20, 2024 | 0 |
| Campbell Wendy Pizarro | Chief Admin. and Legal Officer | – | Jun 20, 2024 | 0 |
| Zulueta Alfonso G | Director | 133,301 | Jan 4, 2024 | 0 |
| Vecchiolla Thomas A. | Director | 365,105 | Dec 26, 2023 | 0 |
| Lee Heehyoung | Director, Other: Former Director | – | Oct 26, 2023 | 0 |
| Weber William John | 10% Owner | 1,931,852Indirect | Sep 14, 2023 | 0 |
| First Light Acquisition Group, LLC | 10% Owner | 1,931,852Indirect | Sep 14, 2023 | 0 |
| FLAG Sponsor Manager, LLC | 10% Owner | 1,931,852Indirect | Sep 14, 2023 | 0 |
| Hudson Bay Capital Management LP | 10% Owner | 0Indirect | Sep 14, 2023 | 0 |
| Gerber Sander | 10% Owner | 0Indirect | Sep 14, 2023 | 0 |
| Polar Asset Management Partners Inc. | 10% Owner | 412,800Indirect | Oct 21, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Camaisa AllanDirector | SSale | −850 | $1.46 | −$1.24K | −1.1%77.0K after | |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Schoeneck James ADirector | PPurchase | +75.0K | $2.00 | +$150.0K | +6,613.8%76.1K after | |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Schoeneck James ADirector | PPurchase | +75.0K | – | – | –75.0K after | Derivative |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Poma Eric EChief Executive Officer | PPurchase | +25.0K | $2.00 | +$50.0K | New position25.0K after | |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Poma Eric EChief Executive Officer | PPurchase | +25.0K | – | – | –25.0K after | Derivative |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Leftwich ScottDirector | PPurchase | +125.0K | $2.00 | +$250.0K | +2,212.4%130.7K after | |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Leftwich ScottDirector | PPurchase | +125.0K | – | – | –125.0K after | Derivative |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Jackson Andrew C.Chief Financial Officer | PPurchase | +2.50K | $2.00 | +$5.00K | New position2.50K after | |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Jackson Andrew C.Chief Financial Officer | PPurchase | +2.50K | – | – | –2.50K after | Derivative |
| Dec 18, 2024 (view filing) | Dec 17 | 1 day | Camaisa AllanCEO and Chairman of the Board | SSale | −10.0K | $1.62 | −$16.2K | −13.0%66.7K after | |
| Sep 14, 2023 (view filing)9:00 PM ET | Jun 16-Sep 12 | 90 daysLate | Weber William John and 2 others10% Owner | SSaleClass A Common Stock, par value $0.0001 per share | −477.8K | – | – | –2.10M after | Derivative3 lots |
| Oct 21, 2022 (view filing) | Oct 19 | 2 days | Polar Asset Management Partners Inc.10% Owner | SSaleClass A common stock, par value $0.0001 per share | −36.2K | $9.90 | −$358.4K | −8.1%412.8K after | |
| Sep 14, 2022 (view filing)8:12 PM ET | Sep 12-13 | 2 days | First Light Acquisition Group, LLCChief Executive Officer | SSaleClass A Common Stock, par value $0.0001 per share | −850.0K | $0.5765 | −$490.0K | –2.58M after | Derivative2 lots |